» Articles » PMID: 8149615

International Federation of Clinical Chemistry Standardization Project for Measurements of Apolipoproteins A-I and B. IV. Comparability of Apolipoprotein B Values by Use of International Reference Material

Overview
Journal Clin Chem
Specialty Biochemistry
Date 1994 Apr 1
PMID 8149615
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

We performed temporal and thermal stability studies on SP3-07, a liquid-stabilized reference material for apolipoprotein (apo) B, selected during the previous phase of the International Federation of Clinical Chemistry project on standardization of apolipoprotein measurements. Results indicate that SP3-07 stored at -70 degrees C has the long-term stability required for a reference material. We assigned an accuracy-based apo B value of 1.22 g/L to SP3-07, using a nephelometric method that was calibrated with freshly isolated low-density lipoprotein for which the apo B mass value was determined by a standardized sodium dodecyl sulfate-Lowry procedure. Using a common protocol, the study participants transferred the assigned mass value from SP3-07 to the individual calibrators of the analytical systems and measured the apo B concentration of 20 fresh-frozen samples obtained from individual donors and covering a clinically relevant range of apo B values. The among-laboratory CV on these samples, analyzed by 25 analytical systems, ranged from 3.1% to 6.7%. These results demonstrate the lack of matrix effects of SP3-07 and its ability to provide accurate and comparable apo B values in a variety of immunochemical methods. On the basis of the outcome of these studies, the World Health Organization has endorsed SP3-07 as the International Reference Material for Apolipoprotein B.

Citing Articles

Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association.

Soffer D, Marston N, Maki K, Jacobson T, Bittner V, Pena J J Clin Lipidol. 2024; 18(5):e647-e663.

PMID: 39256087 PMC: 11734832. DOI: 10.1016/j.jacl.2024.08.013.


Exploring Utilization and Establishing Reference Intervals for the Apolipoprotein B Test in the Korean Population.

Choi R, Lee S, Lee E Diagnostics (Basel). 2023; 13(20).

PMID: 37892015 PMC: 10605768. DOI: 10.3390/diagnostics13203194.


Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?.

Cole J, Zubiran R, Wolska A, Jialal I, Remaley A J Clin Med. 2023; 12(17).

PMID: 37685804 PMC: 10488498. DOI: 10.3390/jcm12175737.


Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol.

Contois J, Langlois M, Cobbaert C, Sniderman A J Am Heart Assoc. 2023; 12(15):e030405.

PMID: 37489721 PMC: 10492988. DOI: 10.1161/JAHA.123.030405.


Analysis of the APOB Gene and Apolipoprotein B Serum Levels in a Mexican Population with Acute Coronary Syndrome: Association with the Single Nucleotide Variants rs1469513, rs673548, rs676210, and rs1042034.

Aceves-Ramirez M, Valle Y, Casillas-Munoz F, Martinez-Fernandez D, Parra-Reyna B, Lopez-Moreno V Genet Res (Camb). 2022; 2022:4901090.

PMID: 35440891 PMC: 8991409. DOI: 10.1155/2022/4901090.